Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Roivant Sciences
Roivant Sciences
Health
How a 32-Year-Old CEO Got a Team of Pharma Vets to Join His Radical Approach to Making Drugs
By
Sy Mukherjee
September 21, 2017
Health
Why SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By
Sy Mukherjee
August 9, 2017
Health
This 31-Year-Old CEO Is Snapping Up Drug Industry Veterans Left and Right
By
Sy Mukherjee
July 10, 2017
Health
This 31-Year-Old Just Launched His 5th Biotech Company With a Boost From Merck
By
Sy Mukherjee
June 6, 2017
Most Popular
Economy
As national debt accelerates to $38 trillion, watchdog warns it's 'no way for a great nation like America to run its...
By
Nick Lichtenberg
Success
CEO writes hundreds of thank you notes to staff and still eats in the break room—which 'always, for whatever reason,...
By
Preston Fore
Success
Brené Brown warns American workers are not neurologically wired for this level of rapid change and instability: ‘People...
By
Emma Burleigh
